MRNA - Moderna, Inc. - SEC Form 4 Insider Trading Screener
92 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2020-05-29 | MRNA | Bancel Stephane | CEO | S - Sale | $60.99 | -30,558 | 15,923,819 | 0% | -$1,863,704 | |||||
| D | 2020-05-27 | MRNA | Kim Lorence H. | CFO | S - Sale+OE | $51.13 | -241,000 | 1,202,510 | -17% | -$12,322,330 | |||||
| D | 2020-05-26 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $66.54 | -125,044 | 0 | -100% | -$8,320,428 | |||||
2020-05-26 | MRNA | Hoge Stephen | Pres | S - Sale | $61.85 | -10,000 | 2,000,656 | 0% | -$618,485 | ||||||
| M | 2020-05-21 | MRNA | Flagship Ventures Fund IV General Partner LLC | Dir, 10% | S - Sale | $68.22 | -1,000,000 | 19,274,952 | -5% | -$68,219,276 | |||||
2020-05-22 | MRNA | Bancel Stephane | CEO | S - Sale | $68.92 | -11,046 | 24,403,909 | 0% | -$761,250 | ||||||
| D | 2020-05-20 | MRNA | Henderson Lori M. | GC, Secretary | S - Sale+OE | $70.00 | -64,000 | 0 | -100% | -$4,480,000 | |||||
2020-05-20 | MRNA | Bancel Stephane | CEO | S - Sale | $70.00 | -16,744 | 16,530,075 | 0% | -$1,172,080 | ||||||
| D | 2020-05-19 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $78.16 | -125,044 | 0 | -100% | -$9,773,439 | |||||
| DM | 2020-05-15 | MRNA | Kim Lorence H. | CFO | S - Sale+OE | $80.85 | -261,000 | 1,202,510 | -18% | -$21,101,992 | |||||
2020-05-15 | MRNA | Bancel Stephane | CEO | S - Sale | $65.56 | -11,046 | 24,431,699 | 0% | -$724,200 | ||||||
| M | 2020-05-12 | MRNA | Hoge Stephen | Pres | S - Sale | $64.56 | -10,000 | 2,010,656 | 0% | -$645,615 | |||||
| D | 2020-05-13 | MRNA | Andres Juan | See remarks | S - Sale+OE | $64.67 | -127,500 | 0 | -100% | -$8,244,843 | |||||
| D | 2020-05-12 | MRNA | Kim Lorence H. | CFO | S - Sale+OE | $64.49 | -241,000 | 1,222,510 | -16% | -$15,541,142 | |||||
| D | 2020-05-12 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $64.43 | -125,044 | 0 | -100% | -$8,055,981 | |||||
2020-05-12 | MRNA | Nabel Elizabeth G | Dir | S - Sale | $66.00 | -30,000 | 14,344 | -68% | -$1,980,000 | ||||||
| M | 2020-05-08 | MRNA | Bancel Stephane | CEO | S - Sale | $58.20 | -24,549 | 14,633,873 | 0% | -$1,428,758 | |||||
2020-05-05 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale | $50.48 | -4,770 | 0 | -100% | -$240,790 | ||||||
| D | 2020-05-01 | MRNA | Andres Juan | See remarks | S - Sale+OE | $48.05 | -25,000 | 0 | -100% | -$1,201,309 | |||||
2020-05-01 | MRNA | Bancel Stephane | CEO | S - Sale | $48.70 | -28,442 | 15,894,708 | 0% | -$1,385,125 | ||||||
| M | 2020-04-23 | MRNA | Hoge Stephen | Pres | S - Sale | $49.12 | -10,000 | 2,020,656 | 0% | -$491,232 | |||||
2020-04-24 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale | $47.15 | -10,000 | 4,770 | -68% | -$471,500 | ||||||
2020-04-24 | MRNA | Bancel Stephane | CEO | S - Sale | $47.15 | -11,046 | 24,441,745 | 0% | -$520,819 | ||||||
| M | 2020-04-17 | MRNA | Bancel Stephane | CEO | S - Sale | $45.53 | -28,122 | 15,903,406 | 0% | -$1,280,356 | |||||
2020-04-17 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale | $48.81 | -10,000 | 14,770 | -40% | -$488,100 | ||||||
| D | 2020-04-15 | MRNA | Andres Juan | See remarks | S - Sale+OE | $37.11 | -23,403 | 0 | -100% | -$868,448 | |||||
2020-04-15 | MRNA | Kim Lorence H. | CFO | S - Sale | $36.21 | -20,000 | 1,222,510 | -2% | -$724,230 | ||||||
2020-04-13 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale | $32.00 | -10,000 | 24,770 | -29% | -$320,000 | ||||||
2020-04-13 | MRNA | Hoge Stephen | Pres | S - Sale | $32.39 | -10,000 | 2,030,656 | 0% | -$323,898 | ||||||
2020-04-13 | MRNA | Bancel Stephane | CEO | S - Sale | $32.00 | -23,601 | 15,914,880 | 0% | -$755,232 | ||||||
| D | 2020-04-06 | MRNA | Andres Juan | See remarks | S - Sale+OE | $35.13 | -300 | 0 | -100% | -$10,539 | |||||
2020-04-03 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale | $32.81 | -10,000 | 34,770 | -22% | -$328,100 | ||||||
| D | 2020-04-03 | MRNA | Andres Juan | See remarks | S - Sale+OE | $35.09 | -13,697 | 0 | -100% | -$480,628 | |||||
2020-04-03 | MRNA | Bancel Stephane | CEO | S - Sale | $32.81 | -11,046 | 24,507,450 | 0% | -$362,419 | ||||||
2020-04-01 | MRNA | Bancel Stephane | CEO | S - Sale | $30.05 | -13,356 | 16,594,980 | 0% | -$401,348 | ||||||
2020-03-27 | MRNA | Bancel Stephane | CEO | S - Sale | $28.37 | -11,046 | 24,531,852 | 0% | -$313,375 | ||||||
2020-03-27 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale | $28.37 | -10,000 | 44,770 | -18% | -$283,700 | ||||||
| M | 2020-03-23 | MRNA | Hoge Stephen | Pres | S - Sale | $26.58 | -10,000 | 2,040,656 | 0% | -$265,812 | |||||
2020-03-20 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale | $29.13 | -10,000 | 54,770 | -15% | -$291,300 | ||||||
2020-03-20 | MRNA | Bancel Stephane | CEO | S - Sale | $29.13 | -25,195 | 15,927,836 | 0% | -$733,930 | ||||||
| DM | 2020-03-17 | MRNA | Andres Juan | See remarks | S - Sale+OE | $31.25 | -31,598 | 0 | -100% | -$987,365 | |||||
2020-03-16 | MRNA | Kim Lorence H. | CFO | S - Sale | $26.19 | -20,000 | 1,242,510 | -2% | -$523,819 | ||||||
2020-03-13 | MRNA | Bancel Stephane | CEO | S - Sale | $21.17 | -11,046 | 24,568,093 | 0% | -$233,857 | ||||||
2020-03-13 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale | $23.00 | -10,000 | 64,770 | -13% | -$230,000 | ||||||
| M | 2020-03-12 | MRNA | Hoge Stephen | Pres | S - Sale | $22.06 | -9,990 | 2,050,656 | 0% | -$220,366 | |||||
2020-03-09 | MRNA | Lee Jennifer Ling | Chief Accounting Officer | S - Sale | $27.33 | -361 | 4,419 | -8% | -$9,866 | ||||||
2020-03-10 | MRNA | Bancel Stephane | CEO | S - Sale | $25.71 | -16,468 | 16,646,546 | 0% | -$423,392 | ||||||
| D | 2020-03-09 | MRNA | Andres Juan | See remarks | S - Sale+OE | $30.00 | -104 | 0 | -100% | -$3,120 | |||||
2020-03-06 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale | $27.98 | -10,000 | 74,770 | -12% | -$279,800 | ||||||
2020-03-06 | MRNA | Bancel Stephane | CEO | S - Sale | $28.89 | -11,046 | 24,600,283 | 0% | -$319,102 | ||||||
2020-03-04 | MRNA | Kim Lorence H. | CFO | S - Sale | $27.71 | -20,000 | 1,262,510 | -2% | -$554,200 | ||||||
| D | 2020-03-02 | MRNA | Andres Juan | See remarks | S - Sale+OE | $30.12 | -3,001 | 0 | -100% | -$90,390 | |||||
| DM | 2020-02-28 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $25.57 | -26,473 | 15,947,820 | 0% | -$676,978 | |||||
| D | 2020-02-28 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $23.38 | -10,000 | 84,770 | -11% | -$233,800 | |||||
| D | 2020-02-27 | MRNA | Andres Juan | See remarks | S - Sale+OE | $33.72 | -8,006 | 0 | -100% | -$269,947 | |||||
| M | 2020-02-25 | MRNA | Kim Lorence H. | CFO | S - Sale | $28.39 | -20,000 | 1,282,510 | -2% | -$567,818 | |||||
2020-02-24 | MRNA | Hoge Stephen | Pres | S - Sale | $18.67 | -10,000 | 2,060,646 | 0% | -$186,700 | ||||||
2020-02-21 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale | $18.47 | -10,000 | 94,770 | -10% | -$184,700 | ||||||
| M | 2020-02-20 | MRNA | Bancel Stephane | CEO | S - Sale | $18.39 | -16,332 | 7,456,986 | 0% | -$300,289 | |||||
2020-02-14 | MRNA | Sagan Paul | Dir | P - Purchase | $19.00 | +52,631 | 514,060 | +11% | +$999,989 | ||||||
2020-02-14 | MRNA | Bancel Stephane | CEO | S - Sale | $19.02 | -11,046 | 24,659,420 | 0% | -$210,095 | ||||||
| M | 2020-02-12 | MRNA | Hoge Stephen | Pres | S - Sale | $19.34 | -10,000 | 2,070,646 | 0% | -$193,350 | |||||
2020-02-07 | MRNA | Kim Lorence H. | CFO | S - Sale | $23.06 | -33,295 | 1,302,510 | -2% | -$767,783 | ||||||
| M | 2020-02-07 | MRNA | Bancel Stephane | CEO | S - Sale | $22.65 | -33,134 | 15,968,463 | 0% | -$750,582 | |||||
2020-02-03 | MRNA | Bancel Stephane | CEO | S - Sale | $20.66 | -4,876 | 16,744,135 | 0% | -$100,738 | ||||||
2020-01-31 | MRNA | Bancel Stephane | CEO | S - Sale | $20.43 | -11,046 | 24,713,476 | 0% | -$225,633 | ||||||
| M | 2020-01-27 | MRNA | Kim Lorence H. | CFO | S - Sale | $23.02 | -24,705 | 1,335,805 | -2% | -$568,786 | |||||
| M | 2020-01-23 | MRNA | Hoge Stephen | Pres | S - Sale | $21.61 | -10,000 | 2,080,646 | 0% | -$216,073 | |||||
2020-01-24 | MRNA | Bancel Stephane | CEO | S - Sale | $21.22 | -11,046 | 24,724,522 | 0% | -$234,396 | ||||||
2020-01-22 | MRNA | Kim Lorence H. | CFO | S - Sale | $23.04 | -2,000 | 1,360,510 | 0% | -$46,080 | ||||||
2020-01-22 | MRNA | Bancel Stephane | CEO | S - Sale | $23.00 | -15,398 | 24,735,568 | 0% | -$354,154 | ||||||
2020-01-21 | MRNA | Bancel Stephane | CEO | S - Sale | $20.79 | -4,850 | 16,784,063 | 0% | -$100,832 | ||||||
2020-01-17 | MRNA | Bancel Stephane | CEO | S - Sale | $20.96 | -11,046 | 24,755,816 | 0% | -$231,524 | ||||||
2020-01-13 | MRNA | Hoge Stephen | Pres | S - Sale | $19.14 | -10,000 | 2,090,646 | 0% | -$191,400 | ||||||
2020-01-10 | MRNA | Bancel Stephane | CEO | S - Sale | $20.24 | -16,482 | 16,007,195 | 0% | -$333,582 | ||||||
| M | 2020-01-10 | MRNA | Kania Edwin M Jr | 10% | S - Sale | $20.26 | -475,000 | 23,847 | -95% | -$9,623,813 | |||||
| M | 2020-01-02 | MRNA | Bancel Stephane | CEO | S - Sale | $19.21 | -16,160 | 7,568,874 | 0% | -$310,397 | |||||
2019-12-27 | MRNA | Bancel Stephane | CEO | S - Sale | $19.53 | -11,046 | 24,804,493 | 0% | -$215,728 | ||||||
2019-12-20 | MRNA | Bancel Stephane | CEO | S - Sale | $19.69 | -11,046 | 24,815,539 | 0% | -$217,496 | ||||||
2019-12-12 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale | $18.54 | -100,000 | 104,770 | -49% | -$1,854,000 | ||||||
2019-12-13 | MRNA | Bancel Stephane | CEO | S - Sale | $18.53 | -11,046 | 24,826,585 | 0% | -$204,682 | ||||||
2019-12-10 | MRNA | Kania Edwin M Jr | 10% | S - Sale | $18.81 | -100,000 | 498,847 | -17% | -$1,880,840 | ||||||
| M | 2019-12-09 | MRNA | Flagship Ventures Fund IV General Partner LLC | Dir, 10% | S - Sale | $18.81 | -435,855 | 20,253,972 | -2% | -$8,196,936 | |||||
| D | 2019-12-06 | MRNA | Kim Lorence H. | CFO | S - Sale+OE | $20.00 | -238,532 | 1,362,510 | -15% | -$4,770,190 | |||||
2019-12-06 | MRNA | Bancel Stephane | CEO | S - Sale | $20.01 | -11,046 | 24,795,499 | 0% | -$221,081 | ||||||
2019-11-29 | MRNA | Bancel Stephane | CEO | S - Sale | $20.54 | -11,046 | 24,806,545 | 0% | -$226,885 | ||||||
2019-11-22 | MRNA | Bancel Stephane | CEO | S - Sale | $20.48 | -11,046 | 24,817,591 | 0% | -$226,222 | ||||||
| D | 2019-11-20 | MRNA | Hutt Peter Barton | Dir | S - Sale+OE | $20.18 | -200,000 | 3,924 | -98% | -$4,036,000 | |||||
2019-11-15 | MRNA | Bancel Stephane | CEO | S - Sale | $19.03 | -11,046 | 24,828,637 | 0% | -$210,216 | ||||||
2019-11-08 | MRNA | Bancel Stephane | CEO | S - Sale | $17.38 | -11,046 | 24,828,683 | 0% | -$191,979 | ||||||
2019-11-01 | MRNA | Bancel Stephane | CEO | S - Sale | $16.08 | -11,046 | 24,850,729 | 0% | -$177,570 | ||||||
| D | 2019-09-17 | MRNA | Hutt Peter Barton | Dir | S - Sale+OE | $17.63 | -100,000 | 3,924 | -96% | -$1,763,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |